Bristol-Myers Squibb
BMY
#189
Rank
NZ$184.31 B
Marketcap
NZ$90.54
Share price
0.38%
Change (1 day)
-6.27%
Change (1 year)

Bristol-Myers Squibb (BMY) - Total liabilities

Total liabilities on the balance sheet as of September 2025 : NZ$135.92 Billion

According to Bristol-Myers Squibb's latest financial reports the company's total liabilities are NZ$135.92 Billion. A companyโ€™s total liabilities is the sum of all current and non-current debts and obligations.

Bristol-Myers Squibb - Total liabilities on balance sheet (from 2001 to 2025)

Total liabilities by year

Year Total liabilities Change
2024-12-31NZ$135.13 B30.13%
2023-12-31NZ$103.84 B0.35%
2022-12-31NZ$103.48 B-3.58%
2021-12-31NZ$107.32 B-3.92%
2020-12-31NZ$111.70 B-3.85%
2019-12-31NZ$116.18 B273.61%
2018-12-31NZ$31.09 B1.76%
2017-12-31NZ$30.56 B21.94%
2016-12-31NZ$25.06 B-0.99%
2015-12-31NZ$25.31 B5.68%
2014-12-31NZ$23.95 B-15.73%
2013-12-31NZ$28.42 B5.04%
2012-12-31NZ$27.05 B23.47%
2011-12-31NZ$21.91 B9.51%
2010-12-31NZ$20.01 B-10.41%
2009-12-31NZ$22.33 B-24.98%
2008-12-31NZ$29.77 B46.1%
2007-12-31NZ$20.37 B-7.87%
2006-12-31NZ$22.12 B-10.69%
2005-12-31NZ$24.76 B-12.65%
2004-12-31NZ$28.35 B4.36%
2003-12-31NZ$27.17 B-12.58%
2002-12-31NZ$31.08 B-31.12%
2001-12-31NZ$45.12 B

Total liabilities for similar companies or competitors

Company Total liabilities differencediff. Country
Pfizer
PFE
NZ$200.76 B 47.70%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
NZ$134.79 B-0.83%๐Ÿ‡บ๐Ÿ‡ธ USA
Eli Lilly
LLY
NZ$158.13 B 16.34%๐Ÿ‡บ๐Ÿ‡ธ USA
Novartis
NVS
NZ$108.57 B-20.12%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
Sanofi
SNY
NZ$114.63 B-15.66%๐Ÿ‡ซ๐Ÿ‡ท France
AstraZeneca
AZN
NZ$118.90 B-12.52%๐Ÿ‡ฌ๐Ÿ‡ง UK
Johnson & Johnson
JNJ
NZ$197.12 B 45.03%๐Ÿ‡บ๐Ÿ‡ธ USA
AbbVie
ABBV
NZ$236.98 B 74.35%๐Ÿ‡บ๐Ÿ‡ธ USA
Amgen
AMGN
NZ$139.79 B 2.85%๐Ÿ‡บ๐Ÿ‡ธ USA
Biogen
BIIB
NZ$19.09 B-85.95%๐Ÿ‡บ๐Ÿ‡ธ USA